This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ZIVO Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:9R80 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Apr 26	Buy€169,420	Mark Strome	Individual	100,000	€1.69
27 Feb 26	Buy€12,693	HEP Investments, LLC	Company	1,543	€8.23
12 Feb 26	Buy€164,664	Strome Investment Management, L.P.	Company	20,000	€8.23
10 Feb 26	Buy€21,005	HEP Investments, LLC	Company	2,434	€8.63
26 Jan 26	Buy€84,136	John Payne	Individual	11,709	€7.19
26 Jan 26	Buy€84,136	Alison Cornell	Individual	11,709	€7.19
14 Jan 26	Buy€12,866	Christopher Maggiore	Individual	1,766	€7.29
14 Jan 26	Buy€12,866	HEP Investments, LLC	Company	1,766	€7.29
28 Nov 25	Buy€21,554	HEP Investments, LLC	Company	2,777	€7.76
13 Oct 25	Buy€216,072	Strome Investment Management, L.P.	Company	20,259	€10.67
10 Oct 25	Buy€17,198	HEP Investments, LLC	Company	1,659	€10.37
08 Oct 25	Buy€244,829	Christopher Maggiore	Individual	23,682	€10.34
30 Sep 25	Buy€208,812	HEP Investments, LLC	Company	15,322	€13.63

Insider Trading Volume

Insider Buying: 9R80 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9R80?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	17,313	0.63%
Institutions	233,869	8.51%
VC/PE Firms	242,736	8.83%
Individual Insiders	436,747	15.9%
General Public	1,817,502	66.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75%.

Top Shareholders

Top 23 shareholders own 33.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.3%	Christopher Maggiore	336,816	€2.7m	186%	no data
8.83%	HEP Investments, LLC	242,736	€1.9m	0%	no data
4.86%	Armistice Capital LLC	133,645	€1.1m	-21.7%	0.02%
2.5%	Alison Cornell	68,666	€541.0k	1,430%	no data
1.65%	Geode Capital Management, LLC	45,475	€358.3k	0.02%	no data
0.99%	Mark Strome	27,267	€214.8k	0%	no data
0.99%	Strome Investment Management, L.P.	27,114	€213.6k	0%	3.37%
0.79%	The Vanguard Group, Inc.	21,811	€171.8k	12.5%	no data
0.6%	Estate of Robert S. Mclain	16,422	€129.4k	0%	no data
0.073%	Column Capital Advisors, LLC	2,000	€15.8k	0%	no data
0.068%	Wells Fargo & Company, Securities and Brokerage Investments	1,878	€14.8k	0%	no data
0.061%	Verdence Capital Advisors, LLC	1,666	€13.1k	0%	no data
0.057%	John Payne	1,567	€12.3k	0%	no data
0.05%	Andrew Dahl	1,387	€10.9k	0%	no data
0.032%	Tower Research Capital LLC	891	€7.0k	0%	no data
0.032%	Nola Masterson	879	€6.9k	0%	no data
0.006%	Bartlett & Co. LLC	166	€1.3k	0%	no data
0.006%	Philip Rice	165	€1.3k	0%	no data
0.0038%	PNC Financial Services Group Inc., Banking Investments	104	€818.4	0%	no data
0.001%	Royal Bank of Canada, Banking & Securities Investments	28	€220.8	0%	no data
0.00033%	Wells Fargo & Company, Private Banking and Investment Banking Arm	9	€71.4	12.5%	no data
0.00018%	Bourgeon Capital Management, LLC	5	€39.0	0%	no data
0.00004%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€8.7	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/01/23 06:10
End of Day Share Price	2023/10/26 00:00
Earnings	2023/09/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ZIVO Bioscience, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Anthony Vendetti	Maxim Group